BlackRock’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $924M | Buy |
|
|||||
|
2025
Q2 | $916M | Buy |
|
|||||
|
2025
Q1 | $764M | Sell |
|
|||||
|
2024
Q4 | $649M | Buy |
|
|||||
|
2024
Q3 | $631M | Sell |
|
|||||
|
2024
Q2 | $607M | Buy |
|
|||||
|
2024
Q1 | $644M | Sell |
|
|||||
|
2023
Q4 | $603M | Buy |
|
|||||
|
2023
Q3 | $558M | Sell |
|
|||||
|
2023
Q2 | $638M | Buy |
|
|||||
|
2023
Q1 | $715M | Buy |
|
|||||
|
2022
Q4 | $767M | Buy |
|
|||||
|
2022
Q3 | $734M | Sell |
|
|||||
|
2022
Q2 | $773M | Buy |
|
|||||
|
2022
Q1 | $681M | Buy |
|
|||||
|
2021
Q4 | $666M | Buy |
|
|||||
|
2021
Q3 | $559M | Buy |
|
|||||
|
2021
Q2 | $422M | Sell |
|
|||||
|
2021
Q1 | $596M | Buy |
|
|||||
|
2020
Q4 | $453M | Buy |
|
|||||
|
2020
Q3 | $157M | Buy |
|
|||||
|
2020
Q2 | $99.5M | Buy |
|